Immunomodulatory aspects in the progression and treatment of oral malignancy

• Main Authors: Nobuo Kondoh (Author), Masako Mizuno-Kamiya (Author), Naoki Umemura (Author), Eiji Takayama (Author), Harumi Kawaki (Author), Kenji Mitsudo (Author), Yasunori Muramatsu (Author), Shinichiro Sumitomo (Author)
• Format: Book
• Published: Elsevier, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Inflammation substantially affects the risk of oral malignancy. Pro-inflammatory cytokine, interferon (IFN)-γ, confers anti-tumor activity using several different mechanisms. Conversely, higher expression of interleukin (IL)-17 is associated with worse prognosis. Monocyte chemotactic protein (MCP)-1...